Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $67.1M | $72.3M | $76.2M | $77.2M | $78.0M | $84.2M | $90.6M | $95.6M | $99.0M | $99.2M |
| Revenue growth | — | 7.9% | 5.3% | 1.3% | 1.1% | 7.9% | 7.6% | 5.5% | 3.6% | 0.2% |
| Operating income | $22.1M | $24.0M | $26.7M | $25.8M | $26.0M | $28.9M | $30.7M | $31.3M | $36.8M | $34.8M |
| Operating margin | 33.0% | 33.2% | 35.0% | 33.4% | 33.3% | 34.3% | 33.8% | 32.8% | 37.2% | 35.0% |
| Net income | $17.2M | $45.6M | $24.2M | $19.0M | $19.4M | $109M | $21.1M | $15.4M | $19.2M | $17.6M |
| Net margin | 25.7% | 63.1% | 31.7% | 24.6% | 24.9% | 129.7% | 23.3% | 16.1% | 19.4% | 17.8% |
| EPS (diluted) | $1.28 | $3.35 | $1.76 | $1.38 | $1.41 | $7.92 | $1.53 | $1.11 | $1.39 | $1.27 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $40.7M | $46.0M | $42.9M | $42.7M | $44.2M | $47.7M | $46.8M | $42.9M | $46.9M | $49.1M |
| Capital expenditures | $60.4M | $9.04M | $4.05M | $5.11M | $2.27M | $13.0M | $13.6M | $7.62M | — | — |
| Free cash flow | -$19.7M | $37.0M | $38.9M | $37.5M | $41.9M | $34.7M | $33.2M | $35.3M | — | — |
| Share buybacks | — | — | — | $221K | $235K | — | — | — | — | — |
| Dividends paid | $35.1M | $36.1M | $36.8M | $37.4M | $38.0M | $38.5M | $39.2M | $39.8M | $40.4M | $41.0M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $3.93M | $3.39M | $5.04M | $6.11M | $5.74M | $22.5M | $7.61M | $8.21M | $7.10M | $6.69M |
| Total assets | $525M | $490M | $484M | $489M | $494M | $598M | $608M | $596M | $581M | $565M |
| Total liabilities | $333M | $279M | $285M | $307M | $335M | $363M | $378M | $395M | $401M | $413M |
| Long-term debt | $316M | $257M | $262M | $274M | $295M | $329M | $343M | $360M | $368M | $375M |
| Shareholders' equity | $191M | $211M | $199M | $182M | $159M | $235M | $229M | $201M | $180M | $152M |
| Retained earnings | $573M | $618M | $642M | $661M | $681M | $790M | $811M | $826M | $845M | $863M |
| Shares (wtd avg diluted) | 13.5B | 13.6B | 13.7M | 13.8M | 13.8M | 13.8M | 13.8M | 13.8M | 13.8M | 13.9M |
Every figure is extracted from UNIVERSAL HEALTH REALTY INCOME TRUST’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.